Bicycle Therapeutics plc American Depositary Shares BCYC
i
Market dataready · fetched 2026-11-12T14:58:54.940Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T14:58:45.33934261Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-12T14:58:54.500305+00:00
Bicycle Therapeutics plc American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.68 | 643.1% | 67.1% | |||
| 25Δ | 1.90 | 591.5% | 60.9% | |||
| 30Δ | 2.13 | 539.9% | 54.7% | |||
| 35Δ | 2.35 | 488.3% | 48.4% | |||
| 40Δ | 2.58 | 436.7% | 42.2% | |||
| 45Δ | 2.80 | 385.1% | 36.0% | |||
| 50Δ | 3.99 | 312.0% | 25.3% | 3.02 | 333.4% | 29.7% |
| 55Δ | 3.71 | 379.4% | 25.3% | 3.25 | 281.8% | 23.5% |
| 60Δ | 3.44 | 446.9% | 25.3% | 3.47 | 230.2% | 17.3% |
| 65Δ | 3.16 | 514.4% | 25.3% | 3.69 | 178.6% | 11.0% |
| 70Δ | 2.89 | 581.9% | 25.3% | 3.92 | 127.0% | 4.8% |
| 75Δ | 2.61 | 649.3% | 25.3% | |||
| 80Δ | 2.34 | 716.8% | 25.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.68
- IV
- 643.1%
- B/E move
- 67.1%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.90
- IV
- 591.5%
- B/E move
- 60.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.13
- IV
- 539.9%
- B/E move
- 54.7%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.35
- IV
- 488.3%
- B/E move
- 48.4%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.58
- IV
- 436.7%
- B/E move
- 42.2%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.80
- IV
- 385.1%
- B/E move
- 36.0%
50Δ
- Pseudo strike
- 3.99
- IV
- 312.0%
- B/E move
- 25.3%
- Pseudo strike
- 3.02
- IV
- 333.4%
- B/E move
- 29.7%
55Δ
- Pseudo strike
- 3.71
- IV
- 379.4%
- B/E move
- 25.3%
- Pseudo strike
- 3.25
- IV
- 281.8%
- B/E move
- 23.5%
60Δ
- Pseudo strike
- 3.44
- IV
- 446.9%
- B/E move
- 25.3%
- Pseudo strike
- 3.47
- IV
- 230.2%
- B/E move
- 17.3%
65Δ
- Pseudo strike
- 3.16
- IV
- 514.4%
- B/E move
- 25.3%
- Pseudo strike
- 3.69
- IV
- 178.6%
- B/E move
- 11.0%
70Δ
- Pseudo strike
- 2.89
- IV
- 581.9%
- B/E move
- 25.3%
- Pseudo strike
- 3.92
- IV
- 127.0%
- B/E move
- 4.8%
75Δ
- Pseudo strike
- 2.61
- IV
- 649.3%
- B/E move
- 25.3%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 2.34
- IV
- 716.8%
- B/E move
- 25.3%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 217.99% | |
| 173.40% | |
| 163.24% | |
| 271.85% | |
| 208.35% | |
| 214.11% | |
| 220.94% | |
| 239.18% | |
| 287.96% | |
| 239.80% | |
| 223.66% | |
| 216.71% | |
| 290.79% | |
| 122.12% | |
| 270.97% | |
| 138.25% |
Biotechnology
BDTX
Black Diamond Therapeutics, Inc., a biotechnology company, discovers and develops small molecule tumor agnostic therapies. The company is headquartered in Cambridge, Massachusetts.
More →BEAM
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in…
More →BHVN
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The…
More →BLTE
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular…
More →BMEA
Description unavailable
More →BMRN
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San…
More →